Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2017-05-11 Earnings Release
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
STADA Arzneimittel AG: Very good start in first quarter 2017
Earnings Release Classification · 100% confidence The document explicitly states it covers the 'Q1/2017' results, showing key figures like Group sales, EBITDA, and Net income for the first quarter, comparing them to Q1/2016. The title mentions 'Very good start in first quarter 2017' and the DGAP-News header includes 'Quarter Results'. This content structure—detailed financial tables and segment performance for a specific interim period (Q1)—is characteristic of an Interim/Quarterly Report. Since it is a comprehensive report detailing financial performance for a period shorter than a year, the appropriate code is 'IR'. It is not an Earnings Release (ER) because it contains detailed segment breakdowns and reconciliation tables, suggesting more depth than just the initial highlights. Q1 2017
2017-05-11 English
Datum:11.05.2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht 1. Quartal 2017' (Interim Report for the 1st Quarter 2017) for STADA Arzneimittel AG. It contains detailed financial tables, including consolidated income statements, key performance indicators (KPIs), and a management discussion and analysis (Konzernzwischenlagebericht) for the specified period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2017
2017-05-11 German
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in voting rights percentages (e.g., crossing the 3% threshold) held by BlackRock, Inc. in STADA Arzneimittel AG, referencing German securities law (WpHG). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Although it mentions 'Voting Rights Announcements' in the header, the content is a formal notification of a change in holding percentage, fitting the 'Major Shareholding Notification' (MRQ) category best, as it details the resulting situation of voting rights attached to shares and instruments.
2017-05-09 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in voting rights percentages (crossing thresholds) by a shareholder (BlackRock, Inc.) in STADA Arzneimittel AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2017-05-05 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages (e.g., 3.13% resulting situation vs. 2.88% previous notification) held by BlackRock, Inc. in STADA Arzneimittel AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a formal disclosure of a major holding crossing a threshold, which is the core function of MRQ.
2017-05-04 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing 'Notification of Major Holdings' regarding the acquisition/disposal of shares with voting rights by BlackRock, Inc. It specifies the date the threshold was crossed (21 Apr 2017) and provides detailed breakdowns of voting rights percentages. This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the core content is a major holding disclosure.
2017-04-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.